be230cLecture9

78 055 019 162 02 028 12 months 1 071 042 120 02

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: 1) 0.71 (0.42, 1.20) 0.2 Revascularization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Adverse events 5c Not reported in all studies NA NA Quality of life 2 21 day– 6 months Not measured NA Re-operation 1 12 months 0.61 (0.39, 0.95) NA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . NA, not applicable. a Number of trials that measured the outcome at each time point is in brackets. b One study did not report the time point at which the outcome was measured. c Adverse events not always reported in full details to allow statistical analysis. Keller Lab Hypothesis L ETTERS Day 4.25 Flk+ Cells • Can We Model Disease? Gene Profile of Cells Overstimulated with Adrenergic Stimulus Mimics Patients with Heart Failure Alpha Myosin Heavy Chain Beta Myosin Heavy Chain 2.5 400 350 300 250 200 150 100 50 0 2 1.5 1 0.5 0 Control PE Ang II Control PE Ang II Angiotensin II Treated Cells are Larger than Baseline Cells Tritiated Leucine Uptake Ang II Tachycardia Induced Myopathic Cell? Aaron Kaplan ANP and Phospholamban 1.8 1.6 1.4 1.2 1 ANP PHOSPHOLAMBAN...
View Full Document

Ask a homework question - tutors are online